Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
18,214 total articles
DouYu International Holdings Limited appointed Ms. Simin Ren as the sole CEO and Chairperson of the Board, and Mr. Jie Gao as Vice President of Investment and a board director following the resignation of former CEO Mr. Shaojie Chen. The company anticipates these leadership changes will not materially affect its business operations or results.
ACM Research announced the expansion of its Ultra C Tahoe semiconductor wet processing platform to support multiple advanced applications in logic and memory device manufacturing. The platform integrates batch and single wafer processes, improving efficiency, reducing chemical use, and enhancing contamination control. Multiple major semiconductor m…
Futu Holdings Limited, a Nasdaq-listed tech-driven online brokerage and wealth management platform, will report its second quarter 2026 financial results on August 20, 2026, before U.S. market open. The company will also hold a conference call to discuss the earnings on the same day, accessible via pre-registration and webcast.
IMC Rare Earths Ltd successfully completed its IPO on the NYSE American, with underwriters exercising their option to purchase an additional 600,000 shares at $5.00 each, raising approximately $3 million more. The total gross proceeds from the upsized offering amount to $23 million which will be used for working capital, exploration, development, l…
Pinnacle Acquisition Corporation, a Cayman Islands blank check company, has priced its initial public offering of 20 million units at $10 each, aiming to raise $200 million. The units will trade on the NYSE under PNAQ.U, with separate trading of Class A shares and rights expected within 52 days. The company intends to pursue mergers or acquisitions…
Dorchester Minerals, L.P. reported a robust financial performance for the second quarter ended June 30, 2026, with net income rising to $30.9 million, or $0.62 per common unit, compared to $12.3 million, or $0.25 per unit, in the same quarter last year. Operating revenues also increased substantially to $56.1 million from $32.4 million. The partner…
BlossomHill Therapeutics, a clinical-stage biopharmaceutical company focusing on innovative small molecule cancer therapies, announced the pricing of its upsized IPO at $16 per share, raising $150 million. The company plans to list on Nasdaq under ticker BLSM, with proceeds to advance development of its lead oncology drug candidates targeting hard-…
Latigo Biotherapeutics, a clinical-stage biopharmaceutical company focused on innovative non-opioid pain medicines, announced the pricing of its upsized initial public offering of 19.2 million shares at $18 per share, expected to raise $345.6 million in gross proceeds. The stock will trade on Nasdaq under the symbol LTGO starting August 7, 2026. Th…
Ticketplus Ltd., a Chile-based technology company serving live entertainment across Latin America, announced the pricing of its initial public offering of 1,875,000 ordinary shares at $8.00 per share, raising approximately $15 million before expenses. The shares will begin trading on the NYSE American under the ticker TP on August 7, 2026, with an …
Team, Inc., a leading global provider of specialty industrial services, announced it will release its Q2 2026 earnings after NYSE market close on August 10, 2026, followed by a conference call on August 11, 2026. The call will cover financial and operational results with a Q&A session for investors.
Tango Therapeutics announced that Dr. Barbara Weber will step down as Executive Chairman of the Board to pursue other interests. The company, focused on precision cancer medicines using synthetic lethality, expressed gratitude for her leadership while reaffirming confidence in its future progress.
Biogen Inc. has completed the acquisition of RayThera Inc., a private biotech focused on small-molecule immunology therapies, to enhance Biogen's immunology portfolio. This acquisition adds multiple assets targeting immune-mediated diseases, with the lead program having entered Phase 1 development recently. The move aligns with Biogen's strategy to…
Grupo Aeroportuario del Pacífico (GAP) announced that Alejandra Soto is stepping down as Investor Relations and Social Responsibility Officer after over 18 years, effective August 7, 2026. CFO Saúl Villarreal will take over the investor relations role. GAP operates 12 airports across Mexico and has holdings in Jamaica airports.
Destination XL Group, Inc. announced the appointment of current Board Chairman Lionel Conacher as Interim Chief Executive Officer effective August 12, 2026, following the retirement of Harvey Kanter. The company is focused on returning to profitability amidst market challenges by evolving its product assortment, promotional strategies, and customer…
LeMaitre Vascular, a medical device company specializing in peripheral vascular disease treatment, will participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference, engaging with investors to discuss its products and market strategies.
Strawberry Fields REIT, a US-based real estate investment trust specializing in healthcare-related properties, announced a cash dividend of $0.17 per common share payable on September 30, 2026. The company owns and manages a portfolio of 142 skilled nursing, assisted living, and long-term acute care facilities across multiple states.
Strawberry Fields REIT, Inc. announced its second quarter 2026 operating results, highlighting full rent collection, increased rental revenues, and net income growth alongside closing a $300 million corporate credit facility to refinance debt and support upcoming acquisitions. The company plans to acquire a hospital campus near Kansas City, expandi…
Oxbridge Re Holdings Limited announces its upcoming Q2 2026 earnings release and conference call. The company is developing an AI infrastructure platform through its AI GridWorks initiative and providing tokenized real-world asset solutions in reinsurance. Oxbridge Re offers property and casualty reinsurance and operates across technology and insur…
Ready Capital Corporation reported a GAAP loss per common share of $0.63 in Q2 2026 and highlighted ongoing progress in its balance sheet repositioning plan, including significant cash generation and debt reduction. The company focused on managing its commercial real estate loan portfolio and Small Business Administration 7(a) lending business, wit…
Microvast Holdings, Inc., a leading company in advanced battery technologies, announced that it will release its consolidated financial results for Q2 2026 after market close on August 10, 2026, followed by a webcast and earnings conference call to discuss results and outlook.
Sanuwave Health, Inc. announced its Q2 FY2026 financial results with revenues of $9.7 million, a 3% decrease year-over-year. Gross margin declined slightly to 76.2%. The company reported a GAAP operating loss of $0.3 million compared to operating income of $1.4 million in the previous year, and a net loss of $0.7 million. Adjusted EBITDA also dropp…
BCP Investment Corporation announced its Q2 2026 financial results featuring net investment income of $0.45 per share, a decline in net asset value due to mark-to-market portfolio markdowns especially in software-related investments, and a reduction in non-accrual investments. The company successfully amended its KeyBank Credit Facility to increase…
Friedman Industries reported strong first quarter fiscal 2027 results with net earnings of $12.8 million on $240 million of sales, marking a 78% year-over-year increase. The record sales volume rose 28% year-over-year, driven by organic growth and the recent Century Metals acquisition. EBITDA nearly doubled to $19.3 million, reflecting effective op…
Serve Robotics Inc. announced robust second quarter 2026 results with over 400% year-over-year revenue growth driven by an expanded portfolio across delivery, branding, and software sectors. The company diversified its robot fleet applications further with new partnerships, including a laundry delivery service alongside existing food, healthcare, a…
Aclaris Therapeutics announces FDA Fast Track designation for modzatinib (ATI-2138) targeting moderate to severe lichen planus, a serious immuno-inflammatory condition with no approved therapies. The designation aims to expedite development and regulatory review, with plans to initiate a Phase 2b trial in Q4 2026.
